Predicting the behavior of novel sugar carriers for dry powder inhaler formulations via the use of a cohesive-adhesive force balance approach

被引:60
作者
Hooton, Jennifer C. [1 ]
Jones, Matthew D. [1 ]
Price, Robert [1 ]
机构
[1] Univ Bath, Dept Pharm & Pharmacol, Pharmaceut Surface Sci Res Grp, Bath BA2 7AY, Avon, England
基金
英国工程与自然科学研究理事会;
关键词
cohesive-adhesive balance; atomic force microscopy; pulmonary drug delivery; surface chemistry; excipients; preformulation;
D O I
10.1002/jps.20618
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The aim of this work was to utilize the recently developed cohesive-adhesive balance (CAB) technique for analyzing quantitative AFM measurements to compare the relative forces of interaction of micronized salbutamol sulfate particles and a selection of specifically grown sugar substrates (beta cyclodextrin, lactose, raffinose, trehalose and xylitol). The interfacial behavior was subsequently related to the in-vitro delivery performance of these sugars as carrier particles in dry powder inhalation (DPI) formulations. The CAB analysis indicated that the rank order of adhesion between salbutamol sulfate and the sugars was P cyclodextrin < lactose < trehalose < raffinose < xylitol. The P cyclodextrin was the only substrate with which salbutamol sulfate demonstrated a greater cohesive behavior. All other sugars exhibited an adhesive dominance. In-vitro deposition performance of the salbutamol sulfate based carrier DPI formulations showed that the rank order of the fine particle fraction (FPF) was beta cyclodextrin > lactose > raffinose > trehalose > xylitol. A linear correlation (R-2=0.9572) was observed between the FPF and cohesive-adhesive ratios of the AFM force measurements. The observed link between CAB analysis of the interactive forces and in-vitro performance of carrier based formulations suggested a fundamental understanding of the relative balance of the various forces of interaction within a dry powder formulation may provide a critical insight into the behavior of these formulations. (c) 2006 Wiley-Liss, Inc.
引用
收藏
页码:1288 / 1297
页数:10
相关论文
共 23 条
  • [1] Atomic force microscopy in analytical biotechnology
    Allen, S
    Davies, MC
    Roberts, CJ
    Tendler, SJB
    Williams, PM
    [J]. TRENDS IN BIOTECHNOLOGY, 1997, 15 (03) : 101 - 105
  • [2] The cohesive-adhesive balances in dry powder inhaler formulations I: Direct quantification by atomic force microscopy
    Begat, P
    Morton, DAV
    Staniforth, JN
    Price, R
    [J]. PHARMACEUTICAL RESEARCH, 2004, 21 (09) : 1591 - 1597
  • [3] The cohesive-adhesive balances in dry powder inhaler formulations II: Influence on fine particle delivery characteristics
    Begat, P
    Morton, DAV
    Staniforth, JN
    Price, R
    [J]. PHARMACEUTICAL RESEARCH, 2004, 21 (10) : 1826 - 1833
  • [4] Influence of excipients and storage humidity on the deposition of disodium cromoglycate (DSCG) in the Twin Impinger
    Braun, MA
    Oschmann, R
    Schmidt, PC
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1996, 135 (1-2) : 53 - 62
  • [5] BRYON PR, 1996, P RESP DRUG DELIVERY, P103
  • [6] Influence of particle size, air flow, and inhaler device on the dispersion of mannitol powders as aerosols
    Chew, NYK
    Chan, HK
    [J]. PHARMACEUTICAL RESEARCH, 1999, 16 (07) : 1098 - 1103
  • [7] Predicting the quality of powders for inhalation from surface energy and area
    Cline, D
    Dalby, R
    [J]. PHARMACEUTICAL RESEARCH, 2002, 19 (09) : 1274 - 1277
  • [8] The mode of drug particle detachment from carrier crystals in an air classifier-based inhaler
    de Boer, AH
    Hagedoorn, P
    Gjaltema, D
    Lambregts, D
    Irngartinger, M
    Frijlink, HW
    [J]. PHARMACEUTICAL RESEARCH, 2004, 21 (12) : 2167 - 2174
  • [9] The influence of formulation on emission, deaggregation and deposition of dry powders for inhalation
    French, DL
    Edwards, DA
    Niven, RW
    [J]. JOURNAL OF AEROSOL SCIENCE, 1996, 27 (05) : 769 - 783
  • [10] Effects of carriers and storage of formulation on the lung deposition of a hydrophobic and hydrophilic drug from a DPI
    Harjunen, P
    Lankinen, T
    Salonen, H
    Lehto, VP
    Järvinen, K
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2003, 263 (1-2) : 151 - 163